glp 1 short term GLP-1 treatment isn't just about the medication. The difference between short-term results and sustainable outcomes comes down to what you do alongside it. If you're on (or considering) GLP-1 therapy, focus on 92% of people stop GLP-1s

Improvement timing varies

Semaglutide reaching an average weight loss of [about] 15% was game-changing in 2021, he said, changing clinical benefit from improvement to remission of other conditions like hypertension, hyperlipidemia and diabetes. Weight loss of 25%, Moreno and Grunvald noted, would reach results obtained by bariatric surgery

It could be due to reduced calorie intake, a change in blood sugar control, or adjustment of the body to the drug

GHK-Cu Versus BPC-157 BPC-157 and GHK-Cu represent the two most popular regenerative peptides for general tissue repair, though their mechanisms and primary applications differ substantially